This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Kehoe, P. G Search for Related Content PubMed PubMed Citation Articles by Kehoe, P. G Social Bookmarking                         What's this?

Review: The renin-angiotensin-aldosterone system and Alzheimer's disease?

Department of Care of the Elderly, University of Bristol, Frenchay Hospital, Frenchay, Bristol, BS16 1LE, UK, Patrick.Kehoe{at}bristol.ac.uk

Epidemiological studies from the last decade have begun to produce evidence that the perceived joint occurrence of vascular disease and Alzheimer's disease (AD), both common elderly disorders more often believed to occur by chance due to their high prevalence, may now actually have a more pathological significance. The following review discusses some of this evidence and the implications for cognitive decline and the development of AD and how a well-known cardiovascular risk factor gene, the apolipoprotein E (APOE) gene, plays a significant role in the molecular genetics of AD. It also introduces and discusses recent and compelling evidence for the involvement of another well-known cardiovascular risk factor gene, the angiotensin-converting enzyme (ACE1) gene, in the pathogenesis of AD. This role is suggested in terms of recent molecular genetic association evidence implicating the ACE1 insertion/deletion (indel) polymorphism, a more recent large haplotype study that greatly extends the ACE1 indel evidence and incorporates knowledge accrued from previous cardiovascular disease-focused ACE1 haplotype studies. Finally, this paper discusses very recent biological evidence that further supports a role for ACE1 and hypothesises a number of readily testable mechanisms by which the ACE1 enzyme and other components of the renin-angiotensin-aldosterone system may be implicated in increased risk and/or the progression of AD.

Key Words: ACE1 • polymorphism • ACE • Ang IV • AT4 • Alzheimer's disease • haplotypes • gene • association • cardiovascular disease • myocardial infarction

References

• Butler R., Morris AD, Struthers AD Angiotensin-converting enzyme gene polymorphism and cardiovascular disease. Clin Science 1997;93:391-400.[Web of Science][Medline] [Order article via Infotrieve]
• Cambien F., Poirier O., Lecerf L. et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992;359:641-3.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Rigat B., Hubert C., Corvol P. et al. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme (DCP1) (dipeptidyl carboxypeptidase 1). Nuc Acids Res 1992;20:1433.[Free Full Text]
• Cambien F., Alhenc-Gelas F., Herberth B. et al. Familial resemblance of plasma angiotensinogen-converting enzyme level - The Nancy study. Am J Hum Genet 1988; 43:774-80.[Web of Science][Medline] [Order article via Infotrieve]
• Tiret L., Rigat B., Visvikis S. et al. Evidence from combined linkage and segregation analysis that a variant of the angiotensin 1 converting enzyme (ACE) gene controls plasma ACE. Am J Hum Genet 1992;51:197-205.[Web of Science][Medline] [Order article via Infotrieve]
• Cox R., Bouzekri N., Martin S. et al. Angiotensin-1-converting enzyme (ACE) plasma concentration is influenced by multiple ACE-linked quantitative trait nucleotides. Hum Mol Genet 2002;11:2969-77.[Abstract/Free Full Text]
• The SOLVD Investigators. Effects of enalapril on survival inpatients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293-302.[Abstract]
• Pfeffer MA, Braunwald E., Moye LA et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1992; 327:669-77.[Abstract]
• The Acute Infarction Ramipril Efficacy (AIRE) study investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993;342:821-8.[Web of Science][Medline] [Order article via Infotrieve]
• Schacter F., Faure-Delanef L., Guenot F. et al. Genetic associations with human longevity at the APOE and ACE loci. Nat Genet 1994;6:29-32.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Davignon J., Gregg RE, Sug CF Apolipoprotein-E polymorphism and atherosclerosis.Atherosclerosis 1988;8:1-21.[Medline] [Order article via Infotrieve]
• Kuusi T., Nieminen MS, Ehnholm C. et al. Apolipoprotein E polymorphism and coronary artery disease: increased prevalence of apolipoprotein E-4 in angiographically verified coronary patients. Arteriosclerosis 1989;9:237-41.[Abstract/Free Full Text]
• Van Bockxmeer FM, Mamotte CDS. Apolipoprotein 4 homozygosity in young men with coronary heart disease. Lancet 1992;340:879-80.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Pedro-Botet J., Senti M., Nogues X. et al. Lipoprotein and apolipoprotein profile in men with ischaemic stroke: role of lipoprotein(a), triglyceride-rich lipoproteins, and apolipoprotein E polymorphism. Stroke 1992;23:1556-62.[Abstract/Free Full Text]
• Saunders AM, Strittmater WJ, Schmechel D. et al.Association of apolipoprotein E allele 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-72.[Abstract/Free Full Text]
• Antuono P., Beyer J. The burden of dementia. Theoret Med 1999;20:3-13.[CrossRef]
• Tanzi RE, Bertram L. New Frontiers in Alzheimer's Disease Genetics. Neuron 2001;32:181-4.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Hardy J., Selkoe DJ The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002;297:353-6.[Abstract/Free Full Text]
• GoateA., Chartier-Harlin MC, Mullan M. et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991;349:704-06.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Sherrington R., Rogaev EI, Liang Y. et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease.Nature 1995;375:754-60.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Rogaev EI, Sherrington R., Rogaeva EA et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 1995;376:775-8.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Strittmatter WJ, Saunders AM, Schmechel D. et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 1993;90:1977-81.[Abstract/Free Full Text]
• Farrer LA, Cupples LA, Haines JL et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 1997; 278:1349-56.[Abstract/Free Full Text]
• Daw E., Payami H., Nemens EJ et al. The Number of Trait Loci in Late-Onset Alzheimer Disease. Am J Hum Genet 2000; 66:196-204.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Poirier J. Apolipoprotein E and cholesterol metabolism in the pathogenesis and treatment of Alzheimer's disease. Trends Mol Med 2003;9:94-101.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• St George-Hyslop PH The molecular genetics of Alzheimer's disease. Biol Psych 2000;47:183-99.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Pericak-Vance MA, Bass MP, Yamaoka LH et al. Complete genomic screen inlate-onset Alzheimer's disease: Evidence for a new locus on chromosome 12. JAMA 1997;278:1237-41.[Abstract/Free Full Text]
• Kehoe P., Wavrant-De Vrieze F., Crook R. et al. A full genome scan for late-onset Alzheimer's disease. Hum Mol Genet 1998;8:237-45.[CrossRef][Web of Science]
• Wu B., Holmans P., Wavrant-De Vrieze F. et al. Genetic studies on chromosome 12p11-12 in late-onset Alzheimer's disease.JAMA 1998;280:619-22.[Abstract/Free Full Text]
• Myers A., Holmans P., Marshall H. et al. Susceptibility locus for Alzheimer's disease on chromosome 10. Science 2000; 290:2304-05.[Abstract/Free Full Text]
• Stewart R. Cardiovascular factors in Alzheimer's disease. J Neuro, Neurosurg Psychiatry 1996;65:143-7.
• Breteler MMB. Vascular Risk factors for Alzheimer's disease: An epidemiologic perspective. Neurobiol Aging 2000;21:153-60.[Web of Science][Medline] [Order article via Infotrieve]
• Skoog I., Lernfelt B., Landahl S. et al. 15-year longitudinal study of blood pressure and dementia. Lancet 1996; 347:11415.
• Hoyer S. The brain insulin signal transduction system and sporadic (type II) Alzheimer disease: an update. J Neural Transm 2002;109:341-60.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Perez A., Morelli L., Cresto JC et al. Degradation of soluble amyloid b-peptides 1-40,1-42, and the Dutch variant 1-40 Q by insulin degrading enzyme from Alzhiemer disease and control brain.Neurochem Res 2000;25:247-55.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Danesh J., Lewington S. Plasma homocysteine and coronary heart disease: systematic review of published epidemiological studies. J Cardiovasc Risk 1998;5:229-32.[Medline] [Order article via Infotrieve]
• Bots ML, Launer JL, Lindemans J. et al. Homocysteine and short term risk of myocardial infarction and stroke in the elderly: the Rotterdam Study. Arch Intern Med 1999; 159:38-44.[Abstract/Free Full Text]
• Perry IJ, Refsum H., Morris RW et al. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet 1995;346:1395-8.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999;340:115-26.[Free Full Text]
• Skoog I., Wallin A., Fredman P. et al.A population study on blood-brain barrier function in 85-year-olds. Neurology 1998;50:966-71.[Abstract/Free Full Text]
• Kehoe PG, Russ C., McIlroy S. et al. Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease. Nat Genet 1999;21:71-2.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Pope A., Hess HH, Lewin E. Studies on the micro chemical pathology of human cerebral cortex. In: Cohen MM, Snider RS (eds.). Morphological and Biochemical correlates of neuronal activity. New York: Harper and Row, 1964;98-111.
• Arregui A., Perry EK, Rossor MN et al. Angiotensin converting enzyme in Alzheimer's Disease: Increased activity in caudate nucleus and cortical areas. J Neurochem 1982;38:1490-2.[Web of Science][Medline] [Order article via Infotrieve]
• Zubenko GS, Volicer L., Direnfield LK et al. Cerebrospinal fluid levels of angiotensin-converting enzyme in Alzheimer's Disease, Parkinson's Disease and supranuclear palsy. Brain Res 1985;238:215-21.
• Zubenko GS, Marquis JK, Volicer L. et al. Cerebrospinal fluid levels of angiotensin-converting enzyme, acetylcholinesterase and dopamine metabolites in dementia associated with Alzheimer's disease and Parkinson's disease:A correlative study. Biol Psychiatry 1986;21:1365-81.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Barnes NM, Cheng CHK, Costall B. et al. Angiotensin converting enzyme density is increased in temporal cortex from patients with Alzhiemer's disease. Eur J Pharmacol 1991; 200:289-92.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Kalaria RN, Harik SI Reduced glucose transported at the blood-brain barrier and in cerebral cortex in Alzheimer's disease. J Neurochem 1989;53:1083-8.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• McGeer EG, Singh EA (1992) Angiotensin-converting enzyme in cortical tissue in Alzheimer's and some other Neurological Diseases. Dementia 1992;3:299-303.[CrossRef][Web of Science]
• Amouyel P., Richard F., Cottel D. et al. The deletion allele of the angiotensin 1 converting enzyme gene as a genetic susceptibility factor for cognitive impairment. Neurosci Letts 1996;217:203-05.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Tysoe C., Galinsky D., Robinson D. et al. Analysis of alpha-1 antichymotrypsin, presenilin-1, angiotensin-converting enzyme, and methylenetetrahydrofolate reductase loci as candidates for dementia. Am J Med Genet (Neuropsych Genet) 1997;74:207-12.[CrossRef]
• Chapman J., Wang N., Treves TA et al. ACE, MTHFR, factor V Leiden, and APOE polymorphisms in patients with vascular and Alzheimer's dementia. Stroke 1998;29:1401-04. 52. Scacchi R., De Bernardini L., Mantuano E. et al. DNA polymorphisms of apolipoprotein B and angiotensin I-converting enzyme genes and relationships with lipid levels in Italian patients with vascular dementia or Alzheimer's disease. Dement Geriatr Cogn Disord 1998;9:186-90.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Shanmugam V., Sell KW, Saha BH Mistyping ACE heterozygotes. PCR Methods Appl 1993;3:120-1.[Web of Science][Medline] [Order article via Infotrieve]
• Lindpaintner K., Pfeffer MA, Kreutz R. et al. A prospective evaluation of an angiotensin-converting enzyme gene polymorphism and the risk of ischaemic heart disease. N Engl J Med 1995;332:706-11.[Abstract/Free Full Text]
• Farrer LA, Sherbatich T., Keryanov SA et al. Association between angiotensin-converting enzyme and Alzheimer disease. Arch Neurol 2000;57:210-14.[Abstract/Free Full Text]
• Yang JD, Feng G., Zhang J. et al. Association between angiotensin-converting enzyme gene and late onset Alzheimer's disease in Han Chinese. Neurosci Letts 2000;295:41-4.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Cheng CY, Hong CJ, Liu HC et al. Study of the association between Alzheimer's disease and angiotensin-converting enzyme gene polymorphism using DNA from lymphocytes. Eur Neurol 2002;47:26-9.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Narain Y., Yip A., Murphy T. et al. The ACE gene and Alzheimer's disease susceptibility. J Med Genet 2000;37:695-7.[Abstract/Free Full Text]
• Lendon CL, Thaker U., Harris JM et al. The angiotensin 1-converting enzyme insertion (I)/deletion (D) polymorphism does not influence the extent of amyloid or tau pathology in patients with sporadic Alzheimer's disease. Neurosci Letts 2002;328:314-18.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Buss S., Muller-Thomsen T., Hock C. et al. No association between DCP1 genotype and late-onset Alzheimer disease. Am J Med Genet 2002;114:440-5.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Myllykangas L., Polvikoski T., Sulkava R. et al. Cardiovascular risk factors and Alzheimer's disease: a genetic association study in a population aged 85 or over. Neurosci Letts 2000;292:195-8.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Hu J., Miyatake F., Aizu Y. et al. Angiotensin-converting enzyme genotype is associated with Alzheimer disease in the Japanese population. Neurosci Letts 1999;277:65-7.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Alvarez R.,Alvarez V., Lahoz CH et al. Angiotensin converting enzyme and endothelial nitric oxide synthase DNA polymorphisms and late onset Alzheimer's disease. J Neurol Neurosurg Psychiatry 1999;67:733-6.[Abstract/Free Full Text]
• Mattila KM, Rinne JO, Roytta M. et al. Dipeptidyl carboxypeptidase 1 (DCP1) and butyrylcholinesterase (BCHE) gene interactions with the apolipoprotein E epsilon4 allele as risk factors in Alzheimer's disease and in Parkinson's disease with coexisting Alzheimer pathology. J Med Genet 2000; 37:766-70.[Abstract/Free Full Text]
• Panza F., Solfrizzi V., D'Introno A. et al. Shifts in angiotensin I converting enzyme insertion allele frequency across Europe: implications in Alzheimer's disease risk. J Neurol Neurosurg Psychiatry 2003 (in press).
• Monastero R., Calderella R., Mannino M. et al. Lack of association between angiotensin converting enzyme polymorphism and sporadic Alzheimer's disease. Neurosci Letts 2002; 335:147-9.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Palumbo B., Cadini D., Nocentini G. et al. Angiotensin converting enzyme deletion allele in different kinds of dementia disorders. Neurosci Letts 1999;267:97-100.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Zuliani G., Ble A., Zanca R. et al. Genetic polymorphisms in older subjects with vascular or Alzheimer's dementia. Acta Neurol Scand 2001;103:304-08.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Prince JA, Feuk L., Sawyer SL et al. Lack of association findings in complex disease: an analysis of 15 polymorphisms in prior candidate genes for sporadic Alzheimer's disease. Eur J Hum Genet 2001;9:437-44.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Isbir T., Agachan B., Yilmaz H. et al. Angiotensin converting enzyme gene polymorphism in Alzheimer's disease. Cell Biochem Funct 2000;18:141-2.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Crawford F., Abdullah L., Schinka J. et al. Gender-specific association of the angiotensin converting enzyme gene with Alzheimer's disease. Neurosci Lett 2000;280:215-19.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Perry RT, Collins JS, Harrell LE, Acton RT, Go RC Investigation of association of 13 polymorphisms in eight genes in southeastern African American Alzheimer disease patients as compared to age-matched controls. Am J Med Genet 2001;105:332-42.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Kehoe PG, Katzov H., Feuk L. et al. Haplotypes extending across ACE are associated with Alzheimer's disease. Hum Mol Genet 2003;12:859-67.[Abstract/Free Full Text]
• Hu J., Igarashi A., Kamata M. et al. Angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide (A beta); retards A beta aggregation, deposition, fibril formation; and inhibits cytotoxicity. J Biol Chem 2001;276:47863-8.[Abstract/Free Full Text]
• McKenzie CA,Abecasis GR, Keavney B. et al. Trans-ethnic fine mapping of a quantitative trait locus for circulating angiotensin 1 converting enzyme (ACE). Hum Mol Genet 2001;10:1077-84.[Abstract/Free Full Text]
• Keavney B., McKenzie CA, Connell JM et al. Measured haplotype analysis of the angiotensin-I converting enzyme gene. Hum Mol Genet 1998;7:1745-51.[Abstract/Free Full Text]
• Farrall M., Keavney B., McKenzie C. et al. Fine-mapping of an ancestral recombination breakpoint in DCP1. Nat Genet 1999;23:270-1.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Soubrier F., Martin S., Alonso A. et al. High-resolution genetic mapping of the ACE-linked QTL influencing circulating ACE activity. Eur J Hum Genet 2002;10:553-61.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• McKenzie CA, Julier C., Forrester T. et al. Segregation and linkage analysis of serum angiotensin 1 converting enzyme levels: evidence from two quantitative loci. Am J Hum Genet 1995;57:1426-35.[Web of Science][Medline] [Order article via Infotrieve]
• Zhu X., Bouzekri N., Southam L. et al. Linkage and association analysis of angiotensin 1 converting enzyme (ACE)-gene polymorphisms with ACE concentration and blood pressure. Am J Hum Genet 2001;68:1139-48.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Johnson GC, Esposito L., Barratt BJ et al. Haplotype tagging for the identification of common disease genes. Nat Genet 2001;29:233-7.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Rieder MJ,Taylor SL, Clark AG et al. Sequence variation in the human angiotensin converting enzyme. Nat Genet 1999;22:59-62.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Vauquelin G., Michotte Y., Smolders I. et al. Cellular targets for angiotensin II fragments: pharmacological and molecular evidence. JRAAS 2002;3:195-204.[Medline] [Order article via Infotrieve]
• Belmin J., Levy BI, Michel JB Changes in the Renin-Angiotensin-Aldosterone Axis in later life. Drugs Aging 1994;5:391-400.[Web of Science][Medline] [Order article via Infotrieve]
• Brazsko JJ, Kupryszewski G.,Witczuk B. et al.Angiotensin II (3-8)-hexapeptide affects motor activity, performance of passive avoidance and a conditioned avoidance response in rats. Neuroscience 1988;27:777-83.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Wright JW, Miller-Wing AV, Shaffer MJ et al. Angiotensin II(3-8) (ANG IV) hippocampal binding: potential role in the facilitation of memory. Brain Res Bull 1993;32: 497-502.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Wright JW, Krebs LT, Stobb JW et al. The angiotensin IV system: functional implications. Front Neuroendocrinol 1995;16:23-52.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Wright JW, Clemens JA, Panetta JA et al. Effects of LY231617 and angiotensin IV on ischaemia-induced deficits in circular water maze and passive avoidance performance in rats. Brain Res 1996;717:1-11.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Wright JW, Stubley L., Pedersen ES et al. Contributions to the brain angiotensin IV-AT4 receptor subtype system to spatiallearning.JNeurosci 1999;19:3952-61.[Abstract/Free Full Text]
• Tchekalarova J., Kambourova T., Georgiev V. Interaction between angiotensin IV and adenosine A(I) receptor related drugs in passive avoidance conditioning in rats. Behav Brain Res 2001;123:113-16.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Kramár EA, Armstrong DL, Ikeda S. et al. The effects of angiotensin IV analogs on long-term potentiation within the CA1 region of the hippocampus in vitro. Brain Res 2001;897:114-21.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Lee J., Chai S., Mendelsohn FA et al. Potentiation of cholinergic transmission in the rat hippocampus by angiotensin IV and LVV-hemorphin-7. Neuropharmacology 2001;40:618-23.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Kakinuma Y., Hama H., Sugiyama F. et al. Anti-apoptotic action of angiotensin fragments to neuronal cells from angiotensinogen knock-out mice. Neurosci Lett 1997;232:16770.
• Kakinuma Y. Impaired blood-brain barrier function in angiotensinogen-deficient mice. Nature Med 1998;4:1078-80.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Pawlikowski M., Kunert-Radek J. Angiotensin IV stimulates the proliferation of rat anterior pituitary cells in vitro. Biochem Biophys Res Commun 1997;232:292-3.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Albiston AL, McDowall SG, Matsacos D. et al. Evidence that the angiotensin IV (AT4) receptor is the enzyme insulin-regulated aminopeptidase. J Biol Chem 2001;276:48623-6.[Abstract/Free Full Text]
• Wright JW, Kramár EA, Meighan SE et al. Extracellular matrix molecules, long-term potentiation, memory consolidation and the brain angiotensin system. Peptides 2002;23:22146.
• Backstrom JR, Giselle PL, Cullen MJ et al. Matrix metalloproteinase-9 (MMP-9) is synthesised in neurons of the human hippocampus and is capable of degrading the amyloid-b peptide (1-40). J Neurosci 1998;16:7910-19.[Web of Science]
• Backstrom JR, Miller CA, Tökés ZA Characterisation of neutral proteinases from Alzheimer-affected and control brain specimens: identification of calcium-dependent metalloproteinases from hippocampus. J Neurochem 1992;58:983-92.[Web of Science][Medline] [Order article via Infotrieve]
• Sims NR Energy metabolism, oxidative stress and neuronal degeneration in Alzheimer's disease. Neurodegeneration 1996;5:435-40.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Manfredi G., Beal MF The role of mitochondria in the pathogenesis of neurodegenerative diseases. Brain Pathol 2000;10:462-72.[Web of Science][Medline] [Order article via Infotrieve]
• Paolisso G., Tagliamonte, MR, De Lucia D. et al. ACE polymorphism and insulin action in older subjects and healthy centenarians. J Am Geriatr Soc 2001;49:610-14.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Parvathy S., Oppong SY, Karran EH et al.Angiotensin-converting enzyme secretase is inhibited by zinc metalloproteinase inhibitors and requires its substrate to be inserted in a lipid bilayer. Biochem J 1997;327:37-43.[Web of Science][Medline] [Order article via Infotrieve]
• Parvathy S., Hussain I., Karran EH et al.Alzheimer's amyloid precursor protein a-secretase is inhibited by hydroxamic acid-based zinc metalloprotease inhibitors: similarities to the angiotensin converting enzyme secretase. Biochemistry 1998;37:1680-5.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Bulpitt CJ, Fletcher AE Cognitive function and angiotensin-converting enzyme inhibitors in comparison with other antihypertensive drugs. J Cardiovasc Pharmacol 1992; 19(suppl 6):S100-S104.[Web of Science][Medline] [Order article via Infotrieve]
• In't Veld BA, Ruitenberg A., Hofman A. et al. Antihypertensive drugs and incidence of dementia: the Rotterdam study. NeurobiolAging 2001;22:407-12.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Journal of Renin-Angiotensin-Aldosterone System, Vol. 4, No. 2, 80-93 (2003)
DOI: 10.3317/jraas.2003.017


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				J. W Wright and J. W Harding The angiotensin AT4 receptor subtype as a target for the treatment of memory dysfunction associated with Alzheimer's disease Journal of Renin-Angiotensin-Aldosterone System, December 1, 2008; 9(4): 226 - 237. [Abstract] [PDF]

				D. J. Lehmann, M. Cortina-Borja, D. R. Warden, A. D. Smith, K. Sleegers, J. A. Prince, C. M. van Duijn, and P. G. Kehoe Large Meta-Analysis Establishes the ACE Insertion-Deletion Polymorphism as a Marker of Alzheimer's Disease Am. J. Epidemiol., August 15, 2005; 162(4): 305 - 317. [Abstract] [Full Text] [PDF]

				H. Katzov, A. M. Bennet, P. Kehoe, B. Wiman, M. Gatz, K. Blennow, B. Lenhard, N. L. Pedersen, U. de Faire, and J. A. Prince A cladistic model of ACE sequence variation with implications for myocardial infarction, Alzheimer disease and obesity Hum. Mol. Genet., November 1, 2004; 13(21): 2647 - 2657. [Abstract] [Full Text] [PDF]

This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Kehoe, P. G Search for Related Content PubMed PubMed Citation Articles by Kehoe, P. G Social Bookmarking                         What's this?